You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma

Article metrics

Article menu

Download PDFPDF

Short Report
Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2024

AbstractFullPdf
Dec 2019111
Jan 2020551
Feb 2020663
Mar 202011112
Apr 202023234
May 202024242
Jun 202025255
Jul 202019192
Aug 202020207
Sep 202035353
Oct 202026265
Nov 202021215
Dec 202019196
Jan 202117173
Feb 202125258
Mar 202129297
Apr 202119194
May 202139394
Jun 202127275
Jul 2021545424
Aug 202120203
Sep 2021343410
Oct 2021414116
Nov 202141415
Dec 202148509
Jan 202243467
Feb 202231338
Mar 202241436
Apr 202232339
May 202248529
Jun 202246506
Jul 202236384
Aug 202245457
Sep 202259593
Oct 202250527
Nov 202258609
Dec 202246463
Jan 202360606
Feb 202350506
Mar 202343456
Apr 2023404315
May 2023272710
Jun 202316165
Jul 202328299
Aug 202318185
Sep 202317173
Oct 2023606040
Nov 2023343413
Dec 202345469
Jan 202466682
Feb 2024686810
Mar 2024232461
Apr 2024323328
May 202420208
Jun 202452516
Jul 2024414415
Aug 2024343314
Sep 2024303417
Total19682008510